JP2007509955A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2007509955A5 JP2007509955A5 JP2006538213A JP2006538213A JP2007509955A5 JP 2007509955 A5 JP2007509955 A5 JP 2007509955A5 JP 2006538213 A JP2006538213 A JP 2006538213A JP 2006538213 A JP2006538213 A JP 2006538213A JP 2007509955 A5 JP2007509955 A5 JP 2007509955A5
- Authority
- JP
- Japan
- Prior art keywords
- use according
- methionine
- protective agent
- administration
- effective amount
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000003223 protective agent Substances 0.000 claims 11
- BASFCYQUMIYNBI-UHFFFAOYSA-N platinum Chemical compound [Pt] BASFCYQUMIYNBI-UHFFFAOYSA-N 0.000 claims 8
- 125000004432 carbon atom Chemical group C* 0.000 claims 6
- 150000001875 compounds Chemical class 0.000 claims 6
- 241001465754 Metazoa Species 0.000 claims 5
- 229960004452 methionine Drugs 0.000 claims 5
- 230000005855 radiation Effects 0.000 claims 5
- FFEARJCKVFRZRR-UHFFFAOYSA-N L-Methionine Natural products CSCCC(N)C(O)=O FFEARJCKVFRZRR-UHFFFAOYSA-N 0.000 claims 4
- FFEARJCKVFRZRR-BYPYZUCNSA-N L-methionine Chemical compound CSCC[C@H](N)C(O)=O FFEARJCKVFRZRR-BYPYZUCNSA-N 0.000 claims 4
- 125000002252 acyl group Chemical group 0.000 claims 4
- 230000000259 anti-tumor effect Effects 0.000 claims 4
- 239000002246 antineoplastic agent Substances 0.000 claims 4
- 230000000973 chemotherapeutic effect Effects 0.000 claims 4
- 238000002512 chemotherapy Methods 0.000 claims 4
- 229910052697 platinum Inorganic materials 0.000 claims 4
- 230000037380 skin damage Effects 0.000 claims 4
- 229930195722 L-methionine Natural products 0.000 claims 3
- 150000003839 salts Chemical class 0.000 claims 3
- 229930182818 D-methionine Natural products 0.000 claims 2
- 206010040844 Skin exfoliation Diseases 0.000 claims 2
- 125000000217 alkyl group Chemical group 0.000 claims 2
- 230000035618 desquamation Effects 0.000 claims 2
- 229930182817 methionine Natural products 0.000 claims 2
- 125000001360 methionine group Chemical group N[C@@H](CCSC)C(=O)* 0.000 claims 2
- 239000008194 pharmaceutical composition Substances 0.000 claims 2
- MIQJGZAEWQQAPN-YFKPBYRVSA-N (2s)-2-amino-4-methylsulfanylbutan-1-ol Chemical compound CSCC[C@H](N)CO MIQJGZAEWQQAPN-YFKPBYRVSA-N 0.000 claims 1
- FFEARJCKVFRZRR-SCSAIBSYSA-N D-methionine Chemical compound CSCC[C@@H](N)C(O)=O FFEARJCKVFRZRR-SCSAIBSYSA-N 0.000 claims 1
- 125000000296 D-methionine group Chemical group [H]N([H])[C@@]([H])(C(=O)[*])C([H])([H])C([H])([H])SC([H])([H])[H] 0.000 claims 1
- 206010015150 Erythema Diseases 0.000 claims 1
- GGLZPLKKBSSKCX-YFKPBYRVSA-N L-ethionine Chemical compound CCSCC[C@H](N)C(O)=O GGLZPLKKBSSKCX-YFKPBYRVSA-N 0.000 claims 1
- SFSJZXMDTNDWIX-YFKPBYRVSA-N L-homomethionine Chemical compound CSCCC[C@H](N)C(O)=O SFSJZXMDTNDWIX-YFKPBYRVSA-N 0.000 claims 1
- 125000000393 L-methionino group Chemical group [H]OC(=O)[C@@]([H])(N([H])[*])C([H])([H])C(SC([H])([H])[H])([H])[H] 0.000 claims 1
- 206010028116 Mucosal inflammation Diseases 0.000 claims 1
- 201000010927 Mucositis Diseases 0.000 claims 1
- 206010042496 Sunburn Diseases 0.000 claims 1
- 231100000321 erythema Toxicity 0.000 claims 1
- SFSJZXMDTNDWIX-UHFFFAOYSA-N homomethionine Natural products CSCCCC(N)C(O)=O SFSJZXMDTNDWIX-UHFFFAOYSA-N 0.000 claims 1
- 239000000203 mixture Substances 0.000 claims 1
- -1 normethionine Chemical compound 0.000 claims 1
- 239000011251 protective drug Substances 0.000 claims 1
- 208000003265 stomatitis Diseases 0.000 claims 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US10/694,436 | 2003-10-27 | ||
| US10/694,436 US20050090551A1 (en) | 2003-10-27 | 2003-10-27 | Therapeutic use of methionine for the treatment or prevention of mucositis |
| PCT/US2004/035626 WO2005039554A2 (en) | 2003-10-27 | 2004-10-27 | Therapeutic use of methionine for the treatment or prevention of mucositis |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2007509955A JP2007509955A (ja) | 2007-04-19 |
| JP2007509955A5 true JP2007509955A5 (https=) | 2007-12-06 |
| JP4884974B2 JP4884974B2 (ja) | 2012-02-29 |
Family
ID=34522601
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2006538213A Expired - Fee Related JP4884974B2 (ja) | 2003-10-27 | 2004-10-27 | 粘膜炎の予防及び処置のためのメチオニンの治療上の使用 |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US20050090551A1 (https=) |
| EP (1) | EP1677775B1 (https=) |
| JP (1) | JP4884974B2 (https=) |
| AT (1) | ATE536178T1 (https=) |
| AU (1) | AU2004283756B2 (https=) |
| CA (1) | CA2543870C (https=) |
| ES (1) | ES2376102T3 (https=) |
| WO (1) | WO2005039554A2 (https=) |
Families Citing this family (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7071230B2 (en) * | 1997-10-02 | 2006-07-04 | Board Of Trustees Of Southern Illinois University | Therapeutic use of D-methionine to reduce the toxicity of noise |
| US20070231377A1 (en) * | 2006-03-28 | 2007-10-04 | Novus International Inc. | Compositions for promoting hair growth |
| GB0704718D0 (en) * | 2007-03-12 | 2007-04-18 | Prendergast Patrick T | Compounds and methods for preventing and treating mucositis |
| WO2009094172A2 (en) | 2008-01-22 | 2009-07-30 | Araim Pharmaceuticals, Inc. | Tissue protective peptides and peptide analogs for preventing and treating diseases and disorders associated with tissue damage |
| JP2011514349A (ja) | 2008-03-07 | 2011-05-06 | サイドース・エルエルシー | フルベストラント配合物 |
| KR20120041740A (ko) * | 2009-09-14 | 2012-05-02 | 가부시키가이샤 시세이도 | 자외선 장해 경감 조성물 |
| CN102481277A (zh) * | 2009-09-30 | 2012-05-30 | 株式会社资生堂 | 紫外线损伤减轻口服组合物 |
| US8912228B2 (en) | 2009-10-19 | 2014-12-16 | Scidose Llc | Docetaxel formulations with lipoic acid |
| US8541465B2 (en) | 2009-10-19 | 2013-09-24 | Scidose, Llc | Docetaxel formulations with lipoic acid and/or dihydrolipoic acid |
| US8476310B2 (en) | 2009-10-19 | 2013-07-02 | Scidose Llc | Docetaxel formulations with lipoic acid |
| US7772274B1 (en) | 2009-10-19 | 2010-08-10 | Scidose, Llc | Docetaxel formulations with lipoic acid |
| JP5578997B2 (ja) * | 2010-09-16 | 2014-08-27 | 国立大学法人 大分大学 | がん化学療法誘発脱毛に対する抗脱毛用組成物 |
| US11179468B2 (en) | 2012-04-09 | 2021-11-23 | Eagle Pharmaceuticals, Inc. | Fulvestrant formulations |
| CN112839663A (zh) * | 2018-08-14 | 2021-05-25 | 托斯克公司 | 降低氟尿嘧啶诱发的毒性的方法和组合物 |
| US11446303B2 (en) | 2019-06-21 | 2022-09-20 | Tosk, Inc. | Uridine phosphorylase (UPase) inhibitors for treatment of liver conditions |
| WO2022010778A1 (en) | 2020-07-07 | 2022-01-13 | Tosk, Inc. | Uridine phosphorylase inhibitors to treat or prevent pulmonary disease |
| CN114051974B (zh) * | 2021-11-10 | 2023-01-17 | 广西医科大学 | 一种肝癌模型及其构建方法与应用 |
Family Cites Families (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3652290A (en) * | 1970-08-10 | 1972-03-28 | Merck & Co Inc | Beverages containing stabilized vitamin c |
| US3962429A (en) * | 1973-08-01 | 1976-06-08 | Chugai Seiyaku Kabushiki Kaisha | Method for reducing side effects of aminoglycoside antibiotics and composition therefor |
| US4961926A (en) * | 1987-11-19 | 1990-10-09 | Sloan-Kettering Institute For Cancer Research | Methods for prevention and treatment of mucositis with granulocyte colony stimulating factor |
| US5122369A (en) * | 1990-03-30 | 1992-06-16 | Harmony Health Products, Inc. | Nutrient composition for preventing hair loss |
| AU703079B2 (en) * | 1994-07-01 | 1999-03-11 | Procter & Gamble Company, The | Desquamation compositions |
| JPH08190187A (ja) * | 1995-01-11 | 1996-07-23 | Canon Inc | 情報記録装置 |
| US5667791A (en) * | 1996-05-31 | 1997-09-16 | Thione International, Inc. | X-ray induced skin damage protective composition |
| US6187817B1 (en) * | 1996-10-03 | 2001-02-13 | Southern Illinois University School Of Medicine | Therapeutic use of d-methionine to reduce the toxicity of platinum-containing anti-tumor compounds |
| EP0930877B1 (en) * | 1996-10-03 | 2006-04-19 | Southern Illinois University | D-methionine to reduce the toxicity of platinum-containing anti-tumor compounds |
| ES2338946T3 (es) * | 1998-02-13 | 2010-05-13 | Nutramax Laboratories, Inc. | Agentes y procedimientos para la proteccion, tratamiento y reparacion del tejido conjuntivo. |
| DK1194161T3 (da) * | 1999-07-13 | 2006-02-13 | Biovitrum Ab | Stabile faktor VIII-sammensatninger |
| AU2002249863A1 (en) * | 2000-10-24 | 2002-08-12 | Diatide, Inc. | Stabilization of radiopharmaceutical compositions using hydrophilic thioether or a hydrophilic 6-hydroxy chroman |
| MXPA03004546A (es) * | 2000-11-22 | 2003-09-10 | Rxkinetix Inc | Tratamiento de mucositis. |
| PL363426A1 (en) * | 2001-03-09 | 2004-11-15 | Societe Des Produits Nestle S.A. | Composition improving age-related physiological deficits and increasing longevity |
| KR100949318B1 (ko) * | 2001-11-29 | 2010-03-23 | 사운드 파마슈티칼스 인코퍼레이티드 | 화학요법의 바람직하지 않은 작용을 개선하기 위한 방법과조성물 |
| US20040198841A1 (en) * | 2003-03-13 | 2004-10-07 | Oregon Health & Science University | Use of thiol-based compositions in ameliorating mucosal injury |
| CA2581076A1 (en) * | 2004-09-14 | 2006-03-23 | Molecular Therapeutics, Inc. | D-methionine formulation with improved biopharmaceutical properties |
-
2003
- 2003-10-27 US US10/694,436 patent/US20050090551A1/en not_active Abandoned
-
2004
- 2004-10-27 AU AU2004283756A patent/AU2004283756B2/en not_active Ceased
- 2004-10-27 AT AT04810055T patent/ATE536178T1/de active
- 2004-10-27 WO PCT/US2004/035626 patent/WO2005039554A2/en not_active Ceased
- 2004-10-27 ES ES04810055T patent/ES2376102T3/es not_active Expired - Lifetime
- 2004-10-27 JP JP2006538213A patent/JP4884974B2/ja not_active Expired - Fee Related
- 2004-10-27 EP EP04810055A patent/EP1677775B1/en not_active Expired - Lifetime
- 2004-10-27 CA CA2543870A patent/CA2543870C/en not_active Expired - Fee Related
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2007509955A5 (https=) | ||
| ES2202834T3 (es) | Uso de d-metionina para reducir la toxicidad de farmacos ototoxicos y ruido. | |
| US20100099766A1 (en) | Topical NSAID compositions having sensate component | |
| AU652946B2 (en) | The pharmacological use of certain cystine derivatives | |
| JP2012510953A5 (https=) | ||
| RU2010133489A (ru) | Применение ингибиторов гамма-секретазы для лечения рака | |
| US20110136756A1 (en) | Combination antitumor therapy | |
| IL314360A (en) | Method of synthesizing thyroid hormone analogs and polymorphs thereof | |
| JPH0717501B2 (ja) | 高めた無痛覚を与える製薬製品 | |
| CN101939001B (zh) | 用于治疗卵巢癌的含有紫杉醇的组合 | |
| US20050090551A1 (en) | Therapeutic use of methionine for the treatment or prevention of mucositis | |
| CN1582170A (zh) | 扑热息痛的肠胃外组合物 | |
| RU2004133387A (ru) | Фармацевтический препарат с немедленным высвобождением | |
| RU2008119454A (ru) | Лекарственное средство для защиты моторного нейрона у пациентов с боковым амиотрофическим склерозом | |
| JPH11506732A (ja) | 白血病治療薬の製造に関するベンゾイミダゾール類の使用 | |
| JP5161472B2 (ja) | 鎮痛用組成物 | |
| JP4672257B2 (ja) | エポチロンを含む組成物およびカルチノイド症候群の治療のためのそれらの使用 | |
| BR0316131A (pt) | Acetil-l-carnitina para a prevenção e/ou tratamento de neuropatias periféricas induzidas por agentes anti-câncer | |
| RU2007104176A (ru) | Синтез и применение (-)-бета-элемена, (-)-бета-элеменала, (-)-бета-элеменола, фторида (-)-бета-элемена и их аналогов, а также промежуточных продуктов и композитов | |
| AR018198A1 (es) | Soluciones estables de mitoxantrona, procedimiento para prepararlas, utilizacion de dichas soluciones para la preparacion de medicamentos y losmedicamentos de aplicacion de dichas soluciones para el tratamiento de enfermedades cancerosas | |
| US6472381B1 (en) | Method of treating psoriasis | |
| JP2006514063A5 (https=) | ||
| KR20080034166A (ko) | 감각기관 수용성 이부프로펜 경구 투약 제형 및 동일물의제조 및 사용 방법 | |
| JP2011514356A5 (https=) | ||
| RU2005132175A (ru) | Комбинированное лечение опухолей, включающее неморубицин и лучевую терапию |